Newsroom | 22615 results

EDMONTON, AB--(BUSINESS WIRE)--The Canadian Union of Public Employees Alberta Division (CUPE Alberta) has launched a website and advertising campaign asking the province’s conservative government to “axe the tax” on COVID vaccines. CUPE has launched a website at www.axethevaxtax.ca, which allows Albertans to send a letter to Premier Danielle Smith, NDP leader Naheed Nenshi, and their local MLA protesting the $100 fee charged to Albertans getting a COVID vaccination. CUPE is also advertising on...

DUBLIN--(BUSINESS WIRE)--The "United States Fair-Market Value Compensation Rates for Infectious Diseases KOLs" report has been added to ResearchAndMarkets.com's offering. This report presents fair-market value (FMV) hourly and half-day compensation rates for US-based KOLs in the Infectious Diseases specialty, by percentiles, with averages, for four (4) levels of Thought Leader influences (rare, international, national and local). These defensible market-based rate data are built directly from i...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will present at the Jefferies 2025 London Healthcare Conference on Tuesday, November 18 at 2:00 p.m. GMT / 9:00 a.m. ET / 6:00 a.m. PT in London, United Kingdom. A live webcast of the presentation will be made available under Events & Presentations in the Investors section of the Vir Biotechnology website and will be archived for 30 days....

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO, will participate in a fireside chat at the 8th Annual Evercore HealthCONx Conference being held from December 2-4, 2025. Details of the event are as follows: Eric Easom, Co-Founder, Chairman, President and...

SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2025, together with other business updates. Quarterly Results: Revenue of $41.6 million, Net loss of $(45.1) million, and Adjusted EBITDA of $(10.8) million “We exited the third quarter confident about the future of our business. Cygnus co...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the third quarter of 2025, along with recent product highlights and corporate updates. “Zai Lab is entering the next phase of our growth, powered by the rapid advancement of our global pipeline and supported by a commercially profitable and scalable business in China,” said Dr. Samantha Du, Founder, Chairperson, and CEO of Zai Lab. “With zoci moving into pivotal develop...

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Results Revenue totaled $851.6 million, an increase of 4.4% over the third quarter of 2024 Same facility revenue increased 3.7% compared with the third quarter of 2024, including an increase in revenue per patient day of 2.3% and an increase in patient days of 1.3% Same facility admission...

BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a portfolio of strategic investments in healthcare assets, today reported financial results for the third quarter ended September 30, 2025, and highlighted select corporate progress and achievements. “Innoviva delivered strong t...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate update and reported financial results for the third quarter ended September 30, 2025. "Our third quarter demonstrated exceptional execution across our clinical portfolio," said Marianne De Backer, Chief Executive Officer, Vir Biotechnology. "We completed ECLIPSE 1 enrollment approximately two months ahead of schedule and continue to see strong momentum across ECLIPSE 2 and 3, positioning us well fo...

BROOKLYN, N.Y.--(BUSINESS WIRE)--Hispanic Information and Telecommunication Network, Inc. (HITN), la principal organización de medios de comunicación en español que sirve a los hispanos de EE. UU., presenta un programa especial de Vida y Salud titulado Lo que debes saber sobre la vacunación infantil, que se transmitirá el miércoles 5 de noviembre a las 8:00 p.m. y a las 11:00 p.m. (hora del Este). Este especial de una hora busca ofrecer información confiable y basada en evidencia científica sob...